Biotechnology Jobs

• Stevenage
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation. Partners with the Senior Scientist and cross-functional Clinical Matrix Team on protocol development, regulatory interactions and investigator engagement, with on-site presence 2-3 days per week.

AI-enabled insights

• Zug, Switzerland
• On-site
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation. Partners with the Senior Scientist and cross-functional teams on protocol development, regulatory interactions and investigator engagement, with on-site presence 2-3 days per week.

AI-enabled insights

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical program teams, leading medical monitoring, safety oversight, and clinical data interpretation across studies. Partners with Senior Scientists and cross-functional matrix teams on protocol development, regulatory interactions, and investigator engagement. May guide other physicians on complex multi-study programs within the clinical strategy set by the Clinical Development Lead.

AI

• Baar Onyx
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Serves as the physician within oncology clinical program teams, leading medical monitoring, safety oversight and clinical data interpretation for hematology studies. Partners with a Senior Scientist and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement, with hybrid working at least two days on-site.

AI

• Stevenage
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining predictive biomarkers, patient segmentation and go/no-go decision criteria. Represents Translational Medicine on Clinical Matrix Teams and works across diagnostics, data sciences and external partners to validate assays and deliver biomarker data packages.

NGS · FISH · PCR +5

• Grimsby
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.

IHC/IF · Liquid Biopsy · ctDNA +3

• USA - Pennsylvania - Upper Providence
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Validates predictive, pharmacodynamic and resistance biomarkers using platforms such as NGS, ctDNA, flow cytometry and multi-omic analyses to inform dose selection and go/no-go decisions.

IHC/IF · Liquid Biopsy · ctDNA +3

• London
• Hybrid
• US$189,750 – US$316,250 pa
• Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.

IHC/IF · Liquid Biopsy · ctDNA +3

• Stevenage
• Hybrid
• Director

Senior individual-contributor role building a cardiovascular and cardiometabolic translational biology strategy within a respiratory and immunology research unit. Involves evaluating targets, defining human-relevant mechanistic hypotheses, biomarker strategies, multi-omics and reverse translation, plus business development diligence and external academic partnerships across a matrixed organisation.

• USA - Pennsylvania - Upper Providence
• Hybrid
• Director

Senior individual-contributor role building a cardiovascular and cardiometabolic translational biology strategy within a respiratory and immunology research unit. Involves defining human-relevant mechanistic hypotheses, biomarker strategies, target evaluation, and business development diligence, with matrix influence across clinical, genetics, and portfolio teams.

• London
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety data review and scientific oversight of protocols and analysis plans. Collaborates with cross-functional teams, investigators and thought leaders, and presents results for publications and regulatory submissions. Hybrid role with two to three days per week in office.

Digital Tools

• Waltham, United States
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety data review and scientific oversight of protocols and analysis plans. Collaborates with cross-functional teams, investigators and thought leaders, and presents results for publications and regulatory submissions. Hybrid role with two to three days per week in office.

• USA - Pennsylvania - Upper Providence
• Hybrid · 2–3 days in office
• US$187,275 – US$312,125 pa
• Director

Leads the scientific design and execution of interventional clinical studies within Medical Affairs, providing medical governance, safety oversight and scientific interpretation of protocols and analysis plans. Collaborates with cross-functional teams, investigators and regulators, and presents results for publications and submissions. Hybrid role with two to three days per week in office.

• Waltham, United States
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Sets disease-area strategy, chairs governance forums and scientific advisory boards, and line-manages clinical development leads and medical directors within a global matrix team.

AI/ML

• Stevenage
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and launch. Provides portfolio oversight, chairs governance forums and scientific advisory boards, and line-manages Clinical Development Leads and Medical Directors within a global matrix team.

AI/ML